Journal List > J Korean Med Assoc > v.50(7) > 1041924

Lee: Antiepileptic Drugs

Abstract

Epilepsy is a common and disabling disorder with a protracted course. Medical therapy is the keystone for the treatment of epilepsy. Most patients with more than one well-documented non-provoked seizures require prophylactic antiepileptic treatment. Those with underlying structural abnormalities or other risk factors should probably be treated after a single seizure. The goal of treatment should be the maintenance of normal life, avoidance of seizure-related brain or physical injuries including sudden unexpected death of epileptic patients. Nearly two-thirds of patients are well controlled on a single antiepileptic drug. If the first or second monotherapy improves control of seizure but does not produce seizure freedom, an antiepileptic drug with a different or multiple mechanisms can be added. Strategies for the choice of initial antiepileptic drug or combining drugs should involve the assessment of individual patient-related factors, including seizure types and epilepsy syndrome and pharmacology of antiepileptic drugs. The impact of adverse effects of antiepileptic drugs should not be underestimated. The introduction of many new antiepileptic drugs has provided a wider choice for patients and doctors.

Figures and Tables

Figure 1
Zero-order kinentics of phenytoin.
jkma-50-645-g001
Figure 2
Treatment example of status epilepticus.
jkma-50-645-g002
Table 1
Effective AEDs to various seizure types
jkma-50-645-i001

+: Effective, -: Not effective, Δ: Possibly effective, W: Worsening possibility

*: Worsening possibility in pediatric patients

Table 2
Pharmacokinetic characteristics of AEDs
jkma-50-645-i002

Epoxide: Carbamazepine-epoxide; PB: Phenobarbital; N-DC: N-desmethyl clobazam; MHD: mono hydroxy derivative

Table 3
Pharmacodynamics of AEDs
jkma-50-645-i003

♦♦♦: Degree of evidence

*: Mechanism unknown

References

1. McCorry D, Chadwick D, Marson A. Current drug treatment of epilepsy in adults. Lancet Neurol. 2004. 3:729–735.
crossref
2. Perruca E, Gram L, Avanzini D, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 1998. 39:5–17.
crossref
3. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991. 41:965–972.
crossref
4. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000. 34:314–319.
crossref
5. Engel J, Pedley TA, editors. Epilepsy: A Comprehensive Textbook. 1997. Philadelphia: Lippincott-Raven Publishers;1275–1284.
6. Shorvon S. Handbook of Epilepsy Treatment. 2005. Malden: Blackwell Publishing.
7. Levy RH, Mattson RH, Meldrum BS, Perruca E. Antiepileptic Drugs. 2002. 5th ed. Philadelphia: Lippincott Williams & Wilkins.
TOOLS
Similar articles